Skip to main menu Skip to main content Skip to footer

About Us
- Our Team
Science & Technology
Clinical
Patients
News
Publications
Careers
Contact Us

NT-501 Granted Orphan-Drug Designation for Macular Telangiectasia Type 2 (MacTel)

Home » NT-501 Granted Orphan-Drug Designation for Macular Telangiectasia Type 2 (MacTel)

View PDF Version

Other Posts

Media Contact

Laurie Ferguson
l.ferguson@neurotechusa.com

About Us Science & Technology Clinical Patients News Careers Publications Contact Us Supplier Code of Conduct Policy Accessibility Statement Privacy Policy

Stay Connected with our

and

accounts

Main Phone Number

401-333-3880

Headquarters

900 Highland Corporate Drive, Suite 101

Cumberland, RI 02864

Commercial Office

75 Second Ave, Suite 700

Needham, MA 02494

© Neurotech Pharmaceuticals, Inc. 2024

Designed by Glacial Multimedia.

⇧

Accessibility Tools

Increase Text
Decrease Text
Grayscale
High Contrast
Negative Contrast
Light Background
Links Underline
Readable Font
Reset